TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
P | %ret | 1 | 1 | 1 | -3 | 7 | -1 | 13 | 37 | 30 | 14 |
P | %wins | 0 | 100 | 0 | 100 | 100 | 100 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/3/22 16:18 | 6/1/22 | SGMO | Sangamo Therapeutics, Inc | WA | Health | BioPrd | Biological Products, (No Diag | Parker H Stewart | CA | D | P | 18 | 3.60 | 0 | 5 | 11 | 49 | D | |||||||||||||||
3/19/20 19:55 | 3/18/20 | SGMO | Sangamo Therapeutics, Inc | WA | Health | BioPrd | Biological Products, (No Diag | Parker H Stewart | CA | D | P | 16 | 5.20 | 0 | 3 | 30 | 13 | D | |||||||||||||||
11/15/18 19:08 | 11/14/18 | SGMO | Sangamo Therapeutics, Inc | WA | Health | BioPrd | Biological Products, (No Diag | Parker H Stewart | CA | D | P | 18 | 9.00 | 0 | 2 | 36 | 8 | D | |||||||||||||||
9/7/18 17:45 | 9/7/18 | SGMO | Sangamo Therapeutics, Inc | WA | Health | BioPrd | Biological Products, (No Diag | Parker H Stewart | CA | D | P | 27 | 13.52 | 0 | 2 | 57 | 6 | D | |||||||||||||||
8/9/11 19:14 | 8/9/11 | OGXI | Oncogenex Pharmaceuticals, Inc. | WA | Health | BioPrd | Biological Products, (No Diag | Parker H Stewart | WA | D | P | 30 | 10.09 | 1 | 3 | New | 3 | D | -66 | -32 | -35 | -34 | -41 | -36 | -28 | -22 | -3 | 7 | -1 | 13 | 37 | 30 | |
9/5/06 19:24 | 9/5/06 | TGEN | Targeted Genetics Corp /wa/ | WA | Health | BioPrd | Biological Products, (No Diag | Parker H Stewart | WA | DO | P,CEO | P | 20 | 1.99 | 0 | 10 | 47 | 31 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |